Published in Cancer Weekly, November 6th, 2007
"This study was conducted to review the treatment outcome after FSRT for NPC. Between September 1999 and December 2005, 90 patients with persistent (Group 1: n=34, relapse within 6 months...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.